INTRODUCTION {#sec1-1}
============

Inorganic arsenic compounds are widely distributed in nature and epidemiological evidence exit associating occupational and environmental exposure to arsenic with human carcinogenesis.\[[@ref1]\] For instance, exposure to trivalent and pentavalent forms of arsenic causes characteristic skin alterations (ulceration), including hyperkeratosis and skin cancer.\[[@ref2]\] Studies conducted in Taiwan,\[[@ref3]\] Chile,\[[@ref4]\] and Japan\[[@ref5]\] indicated a connection between arsenic exposure from contaminated drinking water and cancer development among inhabitants. It is also known that arsenic interacts with a wide variety of other substances, metals inclusive potentiating its effects or *vice versa*.\[[@ref6]\] There is growing evidences that sodium arsenite (SA) intoxication can compromise the integrity of the liver in laboratory animals and maybe humans.\[[@ref7]--[@ref10]\] A more recent study suggests the use of antioxidants from medicinal plants and antioxidant-rich foods for the management of arsenicosis\[[@ref11]\] and in hepatoprotection.\[[@ref12]\]

Carcinogenesis is frequently associated with DNA damage, changes in ploidy of cells, and nonrandom chromosome aberrations all of which can result from exposure to arsenicals.\[[@ref11]\] Association between chronic alcohol abuse, cirrhosis, and the development of hepatocellular carcinoma (HCC) is well documented.\[[@ref13][@ref14]\] The use of arsenic contaminated water for brewing ethanol (EtOH) locally cannot be ruled out in community where arsenic contamination is endemic. Acute and chronic EtOH treatment has also been shown to increase the production of reactive oxygen species, lower cellular antioxidant levels, and enhance oxidative stress in many tissues, especially the liver.\[[@ref15]\] EtOH-induced oxidative stress is one of the major mechanism through which EtOH induces liver injury.\[[@ref15]\]

*Aframomum* species are commonly consumed in some other countries of the world as a spice, which also finds application as a notable medicinal plant in Nigeria herbal remedies. Studies carried out on other Aframomum species, e.g. *Aframomum melegueta*,\[[@ref16]\] and *Aframomum danielli*\[[@ref17]\] has been reported to have high antioxidant potentials. However, there is dearth of information on *Aframomum longiscapum* (*AL*) Schumann (Zingiberaceae) especially its phytochemical profile which may be hepatoprotective to an extent or toxic on the other hand. This study was therefore undertaken to evaluate the effect of aqueous extract of *AL* seeds on SA and EtOH-induced toxicities in male Wister albino rats.

MATERIALS AND METHODS {#sec1-2}
=====================

Chemicals {#sec2-1}
---------

Sodium arsenite (BDH Chemicals Ltd., Poole, England) 2.5 mg/kg body weight (corresponding to one-tenth of the oral LD~50~ of SA) was administered to a rat.\[[@ref18]\] EtOH was dissolved in distilled water to prepared 3% EtOH (v/v) and 0.3mL was administered to a rat. All other reagents and chemicals were of analytical grade.

Plant materials {#sec2-2}
---------------

The *AL* seeds were sourced locally from the market in Ibadan, Nigeria, and a specimen was identified at the Herbarium in Botany Department, University of Ibadan. The *AL* seeds were pulverised, 650 g was measured out and macerated in 1300 mL of distilled water for 72 h. The aqueous extract was concentrated in a rotary evaporator, lyophilized and thereafter preserved in a refrigerator at 4°C for further use.

Phytochemical screening {#sec2-3}
-----------------------

A small portion of the dry extract was subjected to the phytochemical test using the method of Trease\[[@ref19]\] to test for flavonoids, alkaloids, tannins, anthraquinones, saponins, and cardenolides.

Experimental animals {#sec2-4}
--------------------

Forty 12-week\'s old Male Wister\'s albino rats weighing between 200 and 250 g were purchased from Covenant Farm, Ibadan, Nigeria, and housed in the Primate Colony Department of Biochemistry, University of Ibadan. They were fed with rat pellets containing carbohydrate, at least 20% protein, 3.5% fat, 9.0% fiber, 1.2% calcium, 0.7% phosphorus, vitamin; mineral per mix purchased from Livestock Feeds Ibadan, Nigeria, and water *ad libitum*.

Experimental protocols {#sec2-5}
----------------------

Animals were distributed randomly into eight groups of five rats each. Group I served as control. Those in group II were given 2.5 mg/kg body weight of SA alone via oral intubation, groups III and IV were administered EtOH (3%w/v) AL (122.5 mg/kg body weight),\[[@ref16]\] respectively. While group V was given SA + EtOH, group VI AL + EtOH and group VII SA + AL. Group VIII were administered SA + *AL* + EtOH. Aqueous extracts of *AL* were administered every third day. Animals in groups VI, VII, and VIII were primed with *AL* and simultaneously fed with SA and EtOH as required. All the rats had free access to rat pellets and distilled water *ad libitum* throughout the period of the study.

Twenty-four hours after the last treatment, the rats was killed by cervical dislocation and whole blood collected. Clastogenic effects were evaluated in the rat bone marrow using the micronucleus assay as previously described.\[[@ref20]\] Two hours prior to be killed, the animals were injected (i.p.) with 0.04% colchicines (1 mL/100g body weight). Bone marrow cells from both femurs were used for preparing slides. The slides were fixed, air-dried, and pre-treated with May-Grunewald solution and subsequently stained with Giemsa solution. The slides were scored for the presence of micronucleated polychromatic erythrocytes (mPCEs) according to a standard procedure by using a light microscope and a tally counter.

Hepatic γ-glutamyl transferase (γ-GT) activities were determined in serum using the method of Sazsz, and Gesellschaft fur Klinische Chemie, respectively, as described.\[[@ref21]\] The activities of alanine amino transferase (ALT) and aspartate amino transferase (AST) were also evaluated based on the method of Reitzman and Frankel as described.\[[@ref22]\] Limited histopathological and sperm quality examinations of the liver and caudal epididymis of the testis, respectively, were performed at the Veterinary Pathology Department, University of Ibadan, Nigeria.

Statistical analysis {#sec2-6}
--------------------

The data were expressed as mean ± standard deviation. Differences between the groups were analyzed by one-way analysis of variance (ANOVA) with the aid of Statistical Package for Social Sciences (SPSS) software, SPSS Inc., Chicago, Standard version 10.0.1. *P* \< 0.05 were considered statistically significant for differences in mean.

RESULTS {#sec1-3}
=======

Phytochemical analysis of aqueous extract of *AL* seed indicated the presence of alkaloids, cardenolides, saponins, and flavonoids and the absence of anthraquinones and tannin \[[Table 1](#T1){ref-type="table"}\]. There was an increase in final body weight of mice in groups I--VII with group IV showing the highest gain in final body weight \[[Table 2](#T2){ref-type="table"}\], an insignificant (*P* \< 0.05) reduction in final body weight of group VIII animals were also observed. Compared to control, liver and relative liver weight in all groups except the EtOH-treated group reduced across board \[[Table 2](#T2){ref-type="table"}\] significantly (*P* \< 0.05). [Table 3](#T3){ref-type="table"} shows induction of mPCEs in rat bone marrow cells after exposure to SA, EtOH and *AL* alone and when co-administered. The mPCEs formed by the SA, EtOH + SA treated group were significant and occur at almost the same frequency. AL appears to induce micronuclei formation with a 2.5-fold increase when administered alone and appears to mitigate SA and EtOH-induced mPCE formation decreasing it by almost 50% when compared to control. [Table 4](#T4){ref-type="table"} shows the serum level of hepatic transaminases (γ-GT, AST and ALT) in sera of treated rats. SA and EtOH co-administration increase the serum level of AST when compared to control significantly (*P* \< 0.05) over three-fold. The γ-GT level was increased two-fold over control but was within a normal range. SA and *AL* single treatment alone also increased the serum level of these transaminases \[[Table 4](#T4){ref-type="table"}\]. However, *AL* when administered with SA in combination with EtOH drastically reduced the level of hepatic transaminases in serum. Sperm count, motility, and viability were affected by SA treatment, co-treatment with SA, EtOH and *AL* resulted in a reduction in sperm counts and motility and viability \[[Table 5](#T5){ref-type="table"}\]. Overall sperm morphology was affected with an increase percentage of abnormal sperm cells across treatment groups compared to control \[[Table 5](#T5){ref-type="table"}\]. A 25% increase in total sperm abnormalities was observed in the groups treated with SA or EtOH only. *AL* alone tend to induce a 62% increase in sperm morphological abnormalities and in groups where it is co-administered with SA and EtOH, which singly exhibited a 50% percentage morphological abnormality relatively lesser than when in the absence of *AL*. Limited histopathology of the liver showed diffuse periportal vacuolar degeneration of hepatocytes with very mild cellular infiltration by mononuclear cells in control rats. In the SA-treated rat there are multiple areas of extensive vacuolar degeneration of hepatocytes. The severity in hepatic degeneration and diffused necrosis cells were more pronounced in the SA and EtOH-treated group. In the aqueous extract of AL seed treated rats, little or no visible lesions were observed, but there were mild hepatic degeneration, congestion of the portal vessels and mononuclear cellular infiltration in the SA, EtOH and aqueous extract of AL seed treated rats. EtOH alone treatment exhibited diffuse periportal vacuoles of hepatocytes with mild cellular infiltration by mononuclear cells.
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Induction of micronucleated polychromatic erythrocytes (mPCEs) in rat bone marrow cells after exposure to sodium arsenite and ethanol, *Aframomum longiscapum*
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Serum level of aspartate amino transferase, γ-- glutamyl transferase and alanine amino transferase in sera of rats (mean ± SD)
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Sperm quality in terms of count, motility, viability, and abnormalities in the treated rats
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DISCUSSION {#sec1-4}
==========

Exposure to arsenite has been linked to diverse effects in both experimental animals and humans.\[[@ref23]--[@ref27]\] As the site of xenobiotics metabolism the liver is an important target organ for arsenic toxicity\[[@ref28]\] upon assimilation. Arsenic has been claimed to be of clinical utility in the treatment of syphilis, amoebiosis, and certain other diseases\[[@ref25]\] and also has been used in Fowler solution in the treatment of arthritis;\[[@ref25]\] however, arsenic intoxication in experimental animals has been associated with hepatic tumors,\[[@ref26]\] the inhibition of testicular steroidogenic function,\[[@ref29]\] and spermatogenesis,\[[@ref27]\] as well as with severe metabolic disorders such as diabetes in humans.\[[@ref23][@ref24]\] It is known that arsenic can act as co-mutagen due to its ability to inhibit the activities of thiol containing enzymes,\[[@ref30]\] such as DNA ligase\[[@ref31]\] resulting in defective DNA replication, repair, recombination and joining of single- and double-stranded DNA breaks.\[[@ref32]\]

Excessive EtOH consumption can result in oxidative stress via mechanisms associated with EtOH metabolism that generate reactive oxygen species (ROS). ROS produced by cellular metabolic activity, and the alcohol-inducible enzyme (cytochrome P450 2E1) involved in EtOH metabolism, and activated hepatic macrophages (Kupffer cells) via EtOH-mediated endotoxemia can deplete cellular antioxidant defence capacity\[[@ref15]\] resulting in oxidative stress. The available evidence indicates that oxidative stress may result in DNA damage,\[[@ref33]\] lipid peroxidation\[[@ref34]\] and promote hepatocyte death. Moreover, oxidative mechanisms can contribute to liver fibrosis, by triggering the release of pro-fibrotic cytokines and collagen gene expression in hepatic stellate cells.\[[@ref35]\]

The application of plants products as drugs is as important to humans as their dietary source of nutrients.\[[@ref36]\] Humans have exploited plants for medicinal use, almost as long as they have cultivated them for food, using all part of plants in the art of healing diseases and enhancing health, within their immediate environment.\[[@ref37]\] Natural products from higher plants have indeed offered humanity, clinically useful drugs, such as reserpine, vincristine, physostigmine, quinine, d-tubocurarine, *ginseng*, and *artemisinin*.\[[@ref38]\] Nigerian flora has contributed immensely to the health care of its populace from antiquity to cure ailments.\[[@ref38]--[@ref40]\] However, little is known about the pharmacological efficacy of most herbal plants in use till date\[[@ref41]\] and their spectrum of activity.

This study examines the protective effect of *AL* to Wister albino rats co-exposure to SA and EtOH. Results from phytochemical studies \[[Table 1](#T1){ref-type="table"}\] show that the plant extract contains flavonoids, alkaloids, cardenolides, and saponins with concomitant absence of anthraquinone and tannins. The presence of these biologically active phytochemical---although assessed qualitatively---indicates that the extract of *AL* may exhibit anti-oxidative properties. Mechanistically, AL may act as an antioxidant to mitigate the deleterious effect of free radicals generated from EtOH metabolism and Kupffer cells via endotoxemia as well as SA-mediated toxicity. The observed increase in body weight of group IV rats fed *AL* only could be due to the androgenic properties of the plant since androgens possess anabolic activity;\[[@ref36]\] EtOH treatment alone also increased body and liver weight, this may be as a result of an increase in DNA synthesis we have earlier demonstrated that EtOH (3%w/v) promotes hepatic DNA synthesis (unpublished data). This increase is observed in all groups where EtOH is present with regard to liver weight gained compared with the control. These observed increases may in part be attributed to EtOH implication in the onset of fatty liver with enhanced cholesterol biosynthesis\[[@ref42]\] and oxidative mechanisms related to hepatic fibrosis with the release of pro-fibrotic cytokines and collagen gene expression in stellate cells.\[[@ref35]\]

Co-administration of SA, AL, and EtOH (group VIII) decreased final body weight and liver weight significantly (*P* \< 0.05) compared with control. The decrease in body and liver weight of group VIII rats may be attributed to the synergy of *AL*, EtOH, and SA co-treatment. Liver weight of rats treated with SA alone \[[Table 2](#T2){ref-type="table"}\] decreases significantly (*P* \< 0.05) compared with control confirming its potential hepatotoxicity. However, there was no significant (*P* \> 0.05) increases in liver weight of the SA and EtOH treated group compared with the control group. A significant (*P* \< 0.05) decrease in liver weight was observed in the *AL*-treated group when compared with groups I, II, III, V, and VI. Since little is known of the efficacy of AL, the decreases in liver weight may be related to the duration of exposure to *AL*. Consequently, its phytochemical anti-oxidative characteristics could have been altered and tend to become pro-oxidants. There was a significant (*P* \< 0.05) decrease in relative liver weight across all the groups when compared with the control. Similarly, the relative liver weight in the *AL*-treated group decreases significantly (*P* \< 0.05) compared with SA and EtOH treated groups.

The results of this study clearly demonstrate that SA, SA, and EtOH treatment significantly (*P* \< 0.05) induced the formation of micronuclei in the polychromatic erythrocytes (mPCEs) of the rat bone marrow cells \[[Table 3](#T3){ref-type="table"}\]. These observations are consistent with earlier observations in our laboratory and those of others on the clastogenic potentials of SA in the bone marrow.\[[@ref7][@ref43]\] In this particular investigation, the induction of mPCEs by SA and EtOH was increased significantly (*P* \< 0.05) more than four-fold when compared with the mPCEs induced in the bone marrow of the control group. Arsenite metabolism generates free radicals that can attack DNA leading to chromosomal breakage. In addition to acetaldehyde formation and other by-products of EtOH metabolism which can form DNA adducts that may increase DNA instability and enhance arsenite clastogenicity. Furthermore, SA and EtOH may have acted in synergy in mPCEs formation. However, from [Table 3](#T3){ref-type="table"}, there was a significant (*P* \< 0.05) decrease in mPCEs induction in the bone marrow in SA, EtOH, and *AL*-treated rats. More than a twofold decrease was observed when compared with groups II and III. This can be attributed to *AL* antioxidant activities that help in scavenging ROS generated from EtOH and arsenite metabolism. Interestingly, there was also a significant (*P* \< 0.05) increase in mPCEs induction in *AL*-treated rats compared with control, but there is no significant (*P* \< 0.05) difference between control and EtOH-treated rats. The increase in mPCEs induction in *AL*-treated rats cannot be explained in the light of its anti-oxidative potentials. The *AL* extract may contain other uncharacterised components or its anti-oxidative characteristics could have been altered and to pro-oxidants with the possibility of having genotoxic effects.

Assessment of the serum activities of hepatic transaminases (γ-GT, ALT, and AST) show that SA alone, SA and EtOH increase serum activity of transaminases. SA and simultaneous administration of EtOH significantly (*P* \< 0.05) increased hepatic γ-GT activity in serum by about two- and threefold compared with the control \[[Table 4](#T4){ref-type="table"}\], this is inductive of hepatotoxicity and oxidative peroxidation in the hepatocyte cell membrane. Increased γ-GT activity in serum has been associated with hepatotoxicity,\[[@ref44]\] chromosomal aberrations,\[[@ref45]\] and oxidative stress in cells.\[[@ref46]\] In the group treated with SA, EtOH and *AL*, the level of γ-GT activity decreased significantly (*P* \< 0.05) when compared with SA alone, SA and EtOH-treated rats. This reduction may be due to the presence of bioactive phytochemicals in the *AL* extract scavenging ROS and thereby reducing hepatocyte lipid peroxidation\[[@ref47]\] and reducing the damage SA and EtOH co-treatment would have induced. SA, SA and EtOH increased serum activity of hepatic transaminases (ALT and AST) \[[Table 4](#T4){ref-type="table"}\] significantly (*P* \< 0.05) compared with control. However, ALT and AST activity decreased significantly (*P* \< 0.05) in serum of the SA and EtOH treated group as well as *AL*-treated rats. The induction of ALT and AST activity following SA has been documented.\[[@ref48]\] It is important to note that these enzymes are mainly intracellular implying that any observed increase in serum is as a result of damage to hepatocyte leading their release into extracellular space resulting in increased plasma activities.

Sperm quality as an index of reproductive toxicity \[[Table 5](#T5){ref-type="table"}\] showed that *AL* treatment caused a significant (*P* \< 0.05) decrease in both sperm counts and motility compared with the control group. This is in accordance with the fact that the use of androgens containing compounds could negatively influence male rat fertility.\[[@ref49]\] Further decrease in sperm motility was also observed in rats treated with SA, EtOH, and AL. However, sperm viability in all treatment groups showed no significant (*P* \> 0.05) effect, implying that AL species could also influence male rat fertility positively.\[[@ref49]\] There was no significant increase in the morphological abnormality in the semen in all groups above what appears normal in this study, although *AL* treatment tends to increase total abnormality alone and in the presence of SA and EtOH co-treatment.

The limited histopathological examinations \[[Figure 1](#F1){ref-type="fig"}\] show very mild cellular infiltration by mononuclear cells in the control group. Severe hepatic degeneration and necrosis was also observed in SA alone, SA and EtOH treated groups. No visible lesion was observed in the group treated with *AL*. However, mild hepatic degeneration and congestion of the portal vessels was observed in *AL*, SA and EtOH treated groups.

![Photomicrograph of the liver sections at different magnifications, (a) Control rat: diffuse periportal vacuolar degeneration of hepatocytes with very mild cellular infiltration by mononuclear cells, (b) Sodium arsenite treated rat: there are multiple areas of extensive vacuolar degeneration of hepatocytes, (c) Sodium arsenite and ethanol treated rat: there is severe hepatic degeneration and necrosis (diffuse), (d) Aqueous extract of Aframomum longiscapum seed treated rat: no visible lesion seen, (e) Sodium arsenite + EtOH + aqueous extract of Aframomum longiscapum seed treated rat: mild hepatic degeneration, mild congestion of the portal vessels and mild mononuclear cellular infiltration, (f) EtOH alone. plates b, d and e are (×400) and a, c and f are (×100) magnification](PR-4-154-g006){#F1}

CONCLUSION {#sec1-5}
==========

Taken together, our findings indicate that the aqueous extract of *AL* may have hepatoprotective effects, ameliorate the hepatotoxic effects of SA and EtOH. The extract of *AL* exhibited anticlastogenic properties by reducing SA-induced micronuclei formation in polychromatic erythrocytes in the bone marrow. In terms of reproductive functions, *AL* has a positive and negative effect on male rat fertility by enhancing semen morphology and decreasing sperm count, motility and viability, respectively. The aqueous extract of *AL* has shown potential of mitigating the effect of arsenicals clastogenicity implicated in chemical-induced carcinogenesis.
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